EMA Explains How To Make Risk Minimization Measures Robust & Effective

 
• By Vibha Sharma

Pharmacovigilance experts speaking at an event organized by the European Medicines Agency discussed the rationale behind revised requirements relating to how drug sponsors must develop and evaluate risk minimization measures and thereby improve the safety of their medicines.

Hands of general practitioner filling paper medical records. Doctor in white coat doing paperwork at workplace with laptop, writing notes, preparing documents, reports, prescription. Close up
Patient and doctor representatives can contribute to user-testing of risk minimization materials • Source: Shutterstock

More from Europe

More from Agency Leadership